Cargando…

Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients

Total parenteral nutrition (TPN) is a life-saving therapy for patients with intestinal failure, but it carries the risk of complications, including an increase in liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) after long-term use. Patients receiving chronic TPN are...

Descripción completa

Detalles Bibliográficos
Autores principales: Dąbrowska, Karolina, Zaczek, Zuzanna, Panczyk, Mariusz, Osowska, Sylwia, Kowalczyk, Paweł, Kramkowski, Karol, Sobocki, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181311/
https://www.ncbi.nlm.nih.gov/pubmed/37432338
http://dx.doi.org/10.3390/nu15092206
_version_ 1785041544151040000
author Dąbrowska, Karolina
Zaczek, Zuzanna
Panczyk, Mariusz
Osowska, Sylwia
Kowalczyk, Paweł
Kramkowski, Karol
Sobocki, Jacek
author_facet Dąbrowska, Karolina
Zaczek, Zuzanna
Panczyk, Mariusz
Osowska, Sylwia
Kowalczyk, Paweł
Kramkowski, Karol
Sobocki, Jacek
author_sort Dąbrowska, Karolina
collection PubMed
description Total parenteral nutrition (TPN) is a life-saving therapy for patients with intestinal failure, but it carries the risk of complications, including an increase in liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) after long-term use. Patients receiving chronic TPN are also exposed to metabolic stress from both the underlying disease and parenteral nutrition. The aim of this study was to compare the concentration of liver transaminases AST and ALT in relation to the rate of oxygen consumption in platelet mitochondria in patients receiving long-term TPN with the degree of oxidative stress induced by lipid emulsions, and to explain their role in cellular energy metabolism and changes in the liver based on the percentage of genomic DNA damage. The study group consisted of 86 TPN patients, while the control group consisted of 86 healthy volunteers who were fed only orally. The results of the study showed that the percentage of molecular oxygen depended on the type of lipid emulsion supplied. Analyzing time on TPN as a factor, we observed a decrease in percentage genomic DNA damage and an increase in percentage molecular oxygen in cells. It remains unclear whether TPN has a direct effect on genomic DNA damage and the level of molecular oxygen in cells during the course of treatment. In conclusion, this study provides important insights into the potential effects of TPN on liver enzymes and cellular metabolism. Further research is needed to better understand the underlying mechanisms and to develop strategies to minimize the risk of complications associated with TPN.
format Online
Article
Text
id pubmed-10181311
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101813112023-05-13 Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients Dąbrowska, Karolina Zaczek, Zuzanna Panczyk, Mariusz Osowska, Sylwia Kowalczyk, Paweł Kramkowski, Karol Sobocki, Jacek Nutrients Article Total parenteral nutrition (TPN) is a life-saving therapy for patients with intestinal failure, but it carries the risk of complications, including an increase in liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) after long-term use. Patients receiving chronic TPN are also exposed to metabolic stress from both the underlying disease and parenteral nutrition. The aim of this study was to compare the concentration of liver transaminases AST and ALT in relation to the rate of oxygen consumption in platelet mitochondria in patients receiving long-term TPN with the degree of oxidative stress induced by lipid emulsions, and to explain their role in cellular energy metabolism and changes in the liver based on the percentage of genomic DNA damage. The study group consisted of 86 TPN patients, while the control group consisted of 86 healthy volunteers who were fed only orally. The results of the study showed that the percentage of molecular oxygen depended on the type of lipid emulsion supplied. Analyzing time on TPN as a factor, we observed a decrease in percentage genomic DNA damage and an increase in percentage molecular oxygen in cells. It remains unclear whether TPN has a direct effect on genomic DNA damage and the level of molecular oxygen in cells during the course of treatment. In conclusion, this study provides important insights into the potential effects of TPN on liver enzymes and cellular metabolism. Further research is needed to better understand the underlying mechanisms and to develop strategies to minimize the risk of complications associated with TPN. MDPI 2023-05-06 /pmc/articles/PMC10181311/ /pubmed/37432338 http://dx.doi.org/10.3390/nu15092206 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dąbrowska, Karolina
Zaczek, Zuzanna
Panczyk, Mariusz
Osowska, Sylwia
Kowalczyk, Paweł
Kramkowski, Karol
Sobocki, Jacek
Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title_full Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title_fullStr Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title_full_unstemmed Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title_short Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients
title_sort molecular oxygen levels and percentages of dna damage in tpn patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181311/
https://www.ncbi.nlm.nih.gov/pubmed/37432338
http://dx.doi.org/10.3390/nu15092206
work_keys_str_mv AT dabrowskakarolina molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT zaczekzuzanna molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT panczykmariusz molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT osowskasylwia molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT kowalczykpaweł molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT kramkowskikarol molecularoxygenlevelsandpercentagesofdnadamageintpnpatients
AT sobockijacek molecularoxygenlevelsandpercentagesofdnadamageintpnpatients